Alliance Pharma Share News (APH)

DIRECTOR DEALINGS: Alliance Pharma Non-Executive Director Buys Shares

BROKER RATINGS SUMMARY: Brewin Dolphin Cut To Hold By Peel Hunt, Numis

Alliance Pharma Trading Satisfactory On Solid Brand Performances

LONDON MORNING BRIEFING: Imperial Tobacco, IAG Lead As Deals Approved

BROKER RATINGS SUMMARY: Liberum Cuts Wolseley To Hold From Buy

Alliance Pharma Posts Fall In Profit On Lower Revenue, Ups Dividend

BROKER RATINGS SUMMARY: Investec Downgrades Barclays To Hold From Buy

Alliance Pharma Finance Director Richard Wright To Step Down

Alliance Pharma Acquires MacuVision For Initial GBP5.5 Million

Tuesday tips round-up: Greene King, Alliance Pharma

Pub operator Greene King has seen a slowdown in its sales for the fiscal year-to-date, but its recent purchase of rival Spirit Pub Company will pay off. In the 36 weeks since the start of the financial year like-for-like sales were ahead by 0.6%, a mediocre result, even if it was partially due to to

Alliance Pharma Says 2014 Pretax Profit To Meet Market Expectations

Wednesday broker round-up UPDATE

Aggreko: Morgan Stanley ups target price from 1350p to 1375p, while leaving its underweight rating unaltered. Alliance Pharma: Canaccord Genuity lowers target price from 35p to 33p reiterating its hold recommendation. Close Brothers Group: UBS moves target price from 1420p to 1430p and keeps a neut

UK BROKER RATINGS: Credit Suisse Upgrades TUI Travel To Outperform

Alliance Pharma To Meet Annual Targets As Interim Profit Declines

UK Earnings, Trading Statements Calendar - Week Ahead